Approvals/TGA/DIFLUCAN fluconazole 50 mg/ 5 mL (after reconstitution) powder for oral suspension bottle

Approved

STANDARD

DIFLUCAN fluconazole 50 mg/ 5 mL (after reconstitution) powder for oral suspension bottle

Pfizer Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: ddd266c721c478ff
Product Name: DIFLUCAN fluconazole 50 mg/ 5 mL (after reconstitution) powder for oral suspension bottle
Artg Id: 59089
Artg Name: DIFLUCAN fluconazole 50 mg/ 5 mL (after reconstitution) powder for oral suspension bottle
Sponsor: Pfizer Australia Pty Ltd
Company Detail Path: /organization/pfizer-australia-pty-ltd
Artg Date: 1997-12-18
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-CMI-04875-3
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2010-PI-03528-3

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

ddd266c721c478ff

Type

Standard